Understanding the Types of Cloning: A Comprehensive Guide for Beginners

1. Introduction: The Science of Genetic Replication

Cloning is frequently mischaracterized as a modern novelty, yet it represents a scientific trajectory that challenges our fundamental understanding of biological development, with roots stretching back over a century to the embryonic manipulations of sea urchins and salamanders.

Broadly defined, cloning is the collection of techniques used to create exact genetic replicas of genes, cells, tissues, or entire organisms. While students often associate the term with complex machinery, nature provides numerous examples of natural cloning: single-celled organisms like bacteria replicate through binary fission, and in humans, identical twins occur naturally when a fertilized egg splits into two distinct embryos. For professional stakeholders in medicine, agriculture, and ethics, distinguishing between the various methodologies of cloning is not merely a technical exercise but a strategic necessity. As these technologies mature, they redefine the boundaries of what is biologically possible, necessitating a sophisticated grasp of their distinct mechanisms and societal implications.

Strategically, the transition from observing natural replication to engineered manipulation has positioned cloning as a cornerstone of modern biotechnology. It serves as a primary catalyst for advancing regenerative medicine, offering the tools to study complex disease pathologies and develop patient-specific therapies that were once considered the realm of science fiction. It has moved the field from a descriptive science, where we simply observed the laws of nature, to an interventional science, allowing researchers to actively engineer genetic outcomes. While “cloning” is used broadly in the media, for the student of biology, it encompasses three distinct scientific pathways: molecular cloning, reproductive cloning, and therapeutic cloning.

2. Molecular Cloning (Gene Cloning)

Molecular cloning, or gene cloning, is the most ubiquitous form of cloning and provides the technological foundation for modern genomics. It involves the insertion of a DNA sequence of interest into an engineered plasmid, or vector, to allow for its propagation within a host organism like E. coli. From an educator’s perspective, this technique is vital because it allows for the high-throughput study of gene function, protein expression, and the development of vaccines.

The workflow typically involves the following essential steps:

• Isolation and Purification: Obtaining high-quality DNA from a donor and separating it from cellular debris.

• Digestion: Utilizing restriction endonucleases (molecular scissors) to cut DNA at specific palindromic recognition sequences, often leaving “sticky ends.”

• Ligation: Using the enzyme DNA ligase to join the isolated DNA fragment into a vector that has been cut with the same enzymes.

• Transformation: Introducing the recombinant vector into a chemically competent host cell via heat shock or electroporation.

• Selection and Screening: Identifying which host cells successfully incorporated the recombinant plasmid.

A core concept for examination is Blue/White screening. In this system, the vector carries an alpha fragment of the lacZ gene. If the host cell (containing the omega fragment) takes up an “empty” vector, the functional β-galactosidase enzyme is formed, which breaks down X-gal in the medium and turns the colony blue. If the target DNA is successfully inserted, it disrupts the lacZ gene, and the resulting colonies appear white. This allows researchers to quickly isolate successfully cloned DNA for downstream applications like T7 RNA polymerase-driven protein expression or site-directed mutagenesis.

Strategic Impact: These technologies enable the mass production of therapeutic proteins. Notable examples include the production of human insulin and the creation of “Polly,” a sheep cloned from cells containing the human Factor IX gene, allowing her to secrete blood-clotting proteins in her milk for hemophilia treatment.

3. Reproductive Cloning: Creating Whole Organisms

Reproductive cloning is the process of creating a complete, living animal that is genetically identical to a donor. This field reached a milestone in 1996 with the birth of Dolly the sheep, the first mammal cloned from an adult somatic cell.

This technology serves several strategic purposes:

• Livestock Production: Replicating high-yield meat or milk producers.

• Disease Study: Creating animal models with specific mutations to observe disease progression.

• Conservation and “Resurrection”: Potential cloning of endangered species or the “resurrection” of pets, such as CC (the first cloned cat, born in 2001).

Students must appreciate the immense technical difficulty in achieving a viable clone. The process is highly inefficient due to the complex requirement of “resetting” specialized adult DNA to an embryonic state. For example, Dolly was the result of only 1 success out of 277 attempts. This high failure rate underscores the challenges of genomic reprogramming in a laboratory environment.

3.1 Animal Cloning Techniques: Embryo Twinning vs. SCNT

Animal cloning is achieved through two methodologies that manipulate different stages of biological development to produce genetically identical organisms.

3.1.1 Embryo Twinning

Embryo twinning is a straightforward method that mimics the natural process of creating identical twins. The key to this technique is timing. You must perform the split very early, typically at the two-cell stage or shortly after, before the cells begin to “specialize” (a process called differentiation).

1. Selection: Scientists start with a very early-stage embryo.

2. The Split: The embryo is manually split in half. To visualize the delicacy of this: early researchers like Hans Spemann actually used tiny nooses made of baby hair to cinch and separate these “sticky” cells.

3. Implantation: The two halves are placed into a surrogate mother’s uterus, where each develops into its own identical animal.

Why it works: Pioneering research by Hans Spemann proved that each cell in an early embryo possesses a complete set of genetic instructions. Because these cells have not yet decided whether to become a heart, a lung, or a claw, each one remains “totipotent”—meaning it has the potential to grow into a full, independent organism.

Embryo twinning is effective but limited because it requires a fertilized egg to start. To clone a specific adult animal that is already alive, we need a much more complex “reset” button.

3.1.2 Somatic Cell Nuclear Transfer (SCNT)

SCNT is the sophisticated process of replicating an existing adult organism. It requires distinguishing between germ cells (haploid sperm/egg) and somatic cells (diploid body cells). In SCNT, the nucleus is removed from a donor’s somatic cell and transferred into an enucleated egg cell (one where the original nucleus has been removed).

It is the gold standard of biological engineering. It allows us to take a cell that already has a “job” (like a skin cell) and trick it into acting like a brand-new embryo.

• The Somatic Cell: You begin by collecting a Somatic Cell—any cell in the body that isn’t a sperm or egg. A famous example is the udder (mammary) cell used to create Dolly the Sheep. These are perfect for cloning because, unlike reproductive cells, they already contain two full sets of chromosomes.

• Enucleation: Next, you take a host egg cell and perform “enucleation.” Picture using a microscopic needle to extract the nucleus like a tiny marble being pulled out of a balloon, leaving the egg as an empty biological vessel.

• The Fusion: This is the mechanical “handshake.” To combine the somatic nucleus with the empty egg, scientists use different tools. For Dolly, they used electrofusion (electrical pulses). In more modern experiments, like the 2024 hypoallergenic cat study, scientists used Cytoplasm Injection Cloning Technology (CICT) and a specialized virus (Sendai Virus) to bridge the two parts together.

The greatest challenge in SCNT is that an adult nucleus has already “shut down” the genes it doesn’t need for its specific job. To succeed, the egg’s cytoplasm must reprogram that adult nucleus, forcing it back to an embryonic state where every gene is ready to be activated to build a new body from scratch.

While embryo twinning replicates an unproven embryo, SCNT allows for the replication of adult organisms with established, high-value traits. When you perform SCNT, you are managing three distinct biological roles. It is a common mistake to think the clone is a “mix” of these three; in reality, the genetic blueprint comes from only one.

4. Therapeutic Cloning: The Future of Regenerative Medicine

Therapeutic cloning (or cell replacement therapy) is not intended to produce a human being; rather, it aims to create patient-specific cell lines for medical treatment. By using SCNT, researchers derive nuclear-transfer embryonic stem cells (ntESC) from the inner cell mass of a blastocyst.

The “holy grail” of this field is histological compatibility. Because ntESCs share the donor’s genome, the resulting tissues do not trigger an immune response. This solves the primary medical hurdle of organ transplantation: the lifelong, debilitating burden of immunosuppressive drugs. Potential applications include:

• Parkinson’s Disease: Replacing dopaminergic neurons.

• Diabetes: Generating new insulin-producing cells.

• Spinal Cord Injury: Using cells marked by Oct4 and SSEA-1 to repair nerve damage.

Strategic Impact: This branch of cloning is a pillar of regenerative medicine because it circumvents immunorejection. Because the resulting ntESCs share the patient’s own genome, they can be differentiated into tissues for Parkinson’s or diabetes treatments without the need for immunosuppressive drugs.

Ethical Debate: The controversy centers on the “argument from potential.” Critics argue that destroying a blastocyst terminates a potential person, while proponents contend that the early embryo—an insentient cluster of cells—lacks the moral status of a developed human and that its transformation into a cell line is a morally permissible use of research material to save existing lives.

Scientific Differentiators: Therapeutic vs. Reproductive Cloning

While the initial technical steps overlap, the divergent clinical intent necessitates a “legal firewall” between the two.

5. Case Study: High-Value Applications

5.1 The Pioneer: Dolly the Sheep

The birth of Dolly at the Roslin Institute shattered a fundamental law of biology. Before 1996, scientists believed that once a cell became “specialized” (like a skin, liver, or udder cell), it was permanently locked into that role. Dolly proved that an adult nucleus could be “reprogrammed” back to an embryonic state, possessing the potential to become any cell in the body.

The Somatic Cell Nuclear Transfer (SCNT) Process:

• Donor Nucleus: Scientists collected a somatic cell (an udder cell) from a white-faced Finn Dorset sheep.

• Enucleated Egg: An egg cell was taken from a Scottish Blackface sheep, and its own nucleus—and thus its genetic “ID”—was surgically removed.

• Fusion: The white-faced donor nucleus was transferred into the “empty” black-faced egg.

• Electrical Pulse: A burst of electricity fused the two and “jump-started” the egg to begin dividing as if it had been fertilized.

The Struggle for Success: Cloning is a feat of extreme endurance. In 1996, the efficiency gap was enormous; it took researchers 277 attempts to produce just one viable lamb.

To prove the experiment worked, the choice of breeds was vital. When the black-faced surrogate mother gave birth to a pure white-faced lamb, the visual contrast provided immediate, “grok-able” proof: Dolly was the genetic twin of the Finn Dorset donor, not the mother who carried her.

Transition: Dolly proved we could create a “copy,” but the next generation of scientists asked: can we make that copy “better” by fixing genetic flaws first?

5.2 The Future: CRISPR-Enhanced Cloning: The Case of “Alsik”

A breakthrough in “therapeutic animals” has emerged through the integration of genome editing and cloning. Researchers targeted the Fel d 1 gene, the primary feline allergen. This gene has two dominant forms: a “long form” expressed in the salivary glands and a “short form” preferentially expressed in the skin.

• Lineage and Technique: To create a homozygous line, researchers first used CRISPR-Cas9 to generate founder cats “Heavy” (mosaic) and “Haemi” (heterozygous). These founders were mated to produce the homozygous offspring “Alsik.” To propagate this trait, the cat Alsik C was successfully cloned from Alsik using Cytoplasm Injection Cloning Technology (CICT).

• Economic Analysis: With 10–30% of the global population suffering from cat allergies, the ability to create a homozygous, hypoallergenic line provides a scalable solution for a massive market currently limited to palliative antihistamines.

Cytoplasm Injection Clone Technology (CICT) serves as the strategic workaround to this “dark cytoplasm” problem. Because the pronucleus cannot be visually identified for extraction in one-cell stage feline embryos, CICT allows for precise injection without the need for visual confirmation of the host pronucleus.

Head-to-Head: Dolly vs. Alsik

Insight: While Dolly was a breakthrough in capability (proving the machine of cloning works), Alsik is a breakthrough in utility (using that machine to deliver a specific, life-improving genetic correction).

Transition: This evolution is moving beyond animals to provide a blueprint for the future of human medicine.

5.2.1 The CICT Strategic Workflow

1. Oocyte Preparation: Collection and arrest of host oocytes at Metaphase II.

2. Enucleation: Removal of the first polar body and adjacent ooplasm containing metaphase II chromosomes.

3. Nuclear Injection: A somatic nucleus (e.g., from an edited donor fibroblast) is co-injected into the perivitelline space of the enucleated recipient oocyte.

4. Fusion and Activation: Reconstructed oocytes are fused via Sendai Virus (SV) or electrical pulse. Chemical activation is achieved through ionomycin followed by 6-dimethylaminopurine (6-DMAP) to stimulate the division of the reconstructed embryo.

While SCNT efficiency remains a concern—notably the 277 attempts required for Dolly—current feline CICT research focuses on overcoming “low cleavage efficiency” to reach commercial viability.

6. Strategic Roadblocks and Prohibitive Capital Expenses

Scientific limitations currently serve as “natural checks” on cloning technology, reinforcing the need for targeted rather than blanket regulation.

• Resource Scarcity (The Oocyte Bottleneck): Therapeutic cloning is currently constrained by a massive capital expense: it is estimated that 280 human oocytes are required to derive a single patient-specific ntESC line. Strategic investment must prioritize artificial gametes (haploidization) or in vitro maturation (IVM) of immature follicles to lower this cost-to-market.

Technical and Safety Specifics

• Tumorigenicity: The risk of teratoma formation remains a primary concern. Clinical data indicates that tumors occur when even a 0.2% concentration of undifferentiated Oct4 and SSEA-1 positive cells (markers of pluripotency) are transplanted alongside differentiated tissues.

• Epigenetic Reprogramming Errors: SCNT often fails to completely “reset” adult donor DNA, leading to low embryo viability and premature senescence in cloned cell lines.

• Mitochondrial Heteroplasmy: Incompatibility between the donor nucleus and the host oocyte’s mitochondria can trigger immune rejection, even in “cloned” autologous grafts.

• Animal Contaminants: Cells grown on animal feeder layers incorporate immunogenic molecules like Neu5Gc and PERVs (Porcine Endogenous Retroviruses). The strategic solution is the transition to human extracellular matrices (utilizing collagen IV, laminin, and fibronectin) to ensure clinical safety.

7. Comparative Summary for Revision

Scaling Analysis: Molecular cloning is currently more scalable than organismal cloning due to the adoption of high-throughput automation. Systems such as iBioFAB and DNA-BOT utilize liquid handlers and CAD software to automate DNA assembly. In contrast, organismal cloning is bottlenecked by the “manual nature of SCNT” and “low oocyte availability.” Furthermore, SCNT faces the challenge of “epigenetic resetting”—the difficulty of ensuring an adult nucleus correctly restarts the embryonic program, often resulting in developmental failure.

8. The Future of Cloning and Societal Trajectory

The convergence of cloning with automation and biofoundries is moving the field toward a “silico-designed” biological future. High-throughput biofoundries now allow for the automated construction of DNA clones, accelerating the development of gene therapies and vaccines.

• De-extinction and Synthetic Biology: Ongoing research aims to resurrect the Woolly Mammoth and develop synthetic chromosomes. However, significant roadblocks remain, most notably mitochondrial heteroplasmy. This is defined as the interspecies incompatibility or immune rejection that occurs when the nuclear donor and ooplasmic host are not autologous, disrupting the mitochondrial-nucleus interactions necessary for development.

• Societal Implications: The prospect of “resurrecting” extinct species or deceased pets presents profound ecological and ethical questions. Furthermore, the risk of tumorigenicity—where undifferentiated stem cells form teratomas post-transplantation—remains a critical safety concern for clinical applications.

As these technologies outpace current legislative debates, there is an urgent need for a unified global framework to ensure that biological replication remains focused on therapeutic advancement rather than unregulated human replication.

8.1 Comparative Analysis of Global Legislative Frameworks

The current international landscape is characterized by a fragmented legal consensus, where varying levels of “permissiveness” create a competitive imbalance in global research capabilities.

The Restrictive Model

Nations such as Canada, through the Assisted Human Reproduction Act (AHRA), adopt a prohibitive stance, permitting research only on “spare” embryos from fertility clinics while strictly banning SCNT. This model prioritizes the “Argument from Potential” over autologous medical utility. Furthermore, the Oviedo Convention represents a significant international restrictive precedent. However, it contains a notable “policy knot”: Article 13 allows for genomic modifications for preventive or therapeutic purposes, yet Article 18 explicitly prohibits the creation of human embryos for research—a contradiction that complicates the development of targeted genetic therapies.

The Permissive Model

In contrast, Singapore, China, and South Korea have established themselves as leaders in regenerative medicine by legalizing the generation of human nuclear-transfer embryonic stem cell (ntESC) lines. These frameworks facilitate major breakthroughs by recognizing the embryo as a distinct moral entity from the sentient patient, allowing for the rapid evolution of patient-specific protocols.

8.2 Regulatory Takeaways and Paradoxes

1. The Diplomatic-Internal Gap: Nations like France and Germany signed the 1998 Protocol on Cloning (banning reproductive applications) while simultaneously maintaining permissive domestic policies that allow the generation of human ntESC lines.

2. The 14-Day Boundary: Most permissive nations utilize the “14-day rule”—the point where the primitive streak appears—as the definitive regulatory boundary for therapeutic bifurcation, marking the onset of individual development.

3. Fear-Based Rigidness: Legislative inertia often stems from a “slippery slope” fear that therapeutic speed will lead to reproductive “leakage” before enforceable barriers are finalized.

9. Conclusion: The Strategic Importance of Cloning

Cloning is an essential tool for understanding the “blueprint of life.” From the fundamental use of molecular cloning in drug development to the potential for therapeutic cloning to eliminate the need for organ donor lists, these technologies allow for the precise management of genetic information. While the ethical debate regarding human applications continues, the strategic mastery of cloning remains vital for protecting biodiversity, curing chronic diseases, and advancing the frontiers of modern medicine.

To safeguard this progress, legislation must strictly distinguish between therapeutic research and reproductive application. By protecting the former, society can foster medical breakthroughs while preventing the ethical pitfalls of unregulated human replication. The future of the field depends upon this balance of technical ambition and vigilant ethical oversight.

Essential Glossary for the Aspiring Geneticist

• Somatic Cell: Any cell in a living body that is not a reproductive (sperm or egg) cell, such as a skin, udder, or muscle cell.

• Enucleated: An egg cell that has had its original nucleus and DNA surgically removed to make room for new genetic material.

• Homozygous: When an organism carries two identical versions of a gene (one from each parent), such as Alsik carrying two copies of the edited CH2 gene.

• Autologous: Derived from the same individual. In medicine, autologous transplants use the patient’s own cells to prevent immune rejection.

• Frameshift Mutation: A genetic edit that shifts the “reading frame” of the DNA sequence, effectively breaking the gene and preventing a specific protein from being formed.

• CICT (Cytoplasm Injection Clone Technology): A modern, more efficient cloning method where the edited genetic material is injected directly into the egg’s cytoplasm.

Image Summary

Question/Answers

What scientific principles and biological mechanisms distinguish therapeutic cloning from reproductive cloning techniques?

The primary distinction between therapeutic and reproductive cloning lies in the intended outcome and the specific developmental path taken after an initial shared laboratory procedure. While both techniques typically utilize somatic cell nuclear transfer (SCNT) to create an embryo, they diverge fundamentally at the blastocyst stage regarding how that embryo is utilized.

The Shared Biological Mechanism: SCNT

Both techniques begin with the scientific principle of nuclear reprogramming, where a differentiated adult cell is “reset” to an embryonic state. The biological mechanism follows these steps:

• Enucleation: The nucleus (containing the DNA) is removed from a mature female egg cell (oocyte).

• Transfer and Fusion: A somatic cell (any body cell other than sperm or egg, such as a skin cell) is isolated from a donor. Its nucleus is then transferred into the enucleated egg using a needle or by using an electrical current to fuse the entire somatic cell with the egg.

• Activation: The reconstructed egg is stimulated by chemical or electrical means to behave like a freshly fertilized egg and begin cleavage (cell division).

Distinguishing Reproductive Cloning

The goal of reproductive cloning is the deliberate production of a complete, live-born organism that is genetically identical to the nuclear donor.

• Implantation: The key distinguishing mechanism is that the resulting blastocyst (a preimplantation embryo of about 64 to 200 cells) is implanted into the uterus of a surrogate mother.

• Gestation: The surrogate mother undergoes a normal period of pregnancy and eventually gives birth to a clone.

• Scientific Objectives: Applications include replicating animals with favorable agricultural traits, producing transgenic livestock for drug production (pharming), or potentially treating human infertility.

Distinguishing Therapeutic Cloning

Also referred to as research cloning or nonreproductive cloning, therapeutic cloning focuses on the creation of embryonic cell lines for medical research and treatment.

• Harvesting Stem Cells: Instead of being implanted in a uterus, the blastocyst is further manipulated in a laboratory setting. Researchers harvest pluripotent embryonic stem cells (ESCs) from the inner cell mass of the blastocyst, a process that results in the destruction of the embryo.

• Laboratory Cultivation: These ESCs are grown in culture dishes and can be induced to differentiate into any cell type in the body, such as nerve, muscle, or insulin-producing cells.

• Regenerative Medicine: The primary scientific principle is to create patient-specific tissues that are genetically identical to the patient. This biological compatibility avoids the risk of immune rejection, circumventing the need for immunosuppressive drugs during transplantation.

Key Scientific Differences

How do ethical concerns regarding embryo status impact global policies on therapeutic research?

Ethical concerns regarding the status of the human embryo serve as the primary catalyst for the divergence in global policies on therapeutic research. These concerns generally center on the moral status of the embryonic stem cell source, often drawing parallels to the abortion debate and the argument that a unique human entity deserving protection emerges at the precise moment of conception.

Impacts on global policy include:

1. Divergent Legislative Frameworks

Global policies are split between nations that permit regulated therapeutic research and those that institute total bans based on the “argument of potential”:

• Permissive/Regulated Policies: Countries like the United Kingdom, Australia, Israel, Japan, India, and China allow therapeutic cloning or the creation of human embryos for stem cell research under specific regulatory limits. For instance, the UK utilizes the Human Fertilisation and Embryology Authority (HFEA) to grant licenses for research into diseases like Parkinson’s and Alzheimer’s.

• Restrictive/Prohibitive Policies: Nations such as Canada, France, and Germany have enacted laws that prohibit the creation of human embryos for research or the cloning of stem cells. Canadian law specifically invokes the notion of “human dignity” to justify its ban.

2. The “14-Day Rule” and Biological Milestones

In many jurisdictions where research is legal, policy is dictated by the Warnock Commission’s 1984 decision, which limits the culture of embryos to 14 days. This timeframe marks the appearance of the primitive streak and the onset of gastrulation, a milestone that some ethicists and policymakers believe confers a higher moral status to the embryo than the earlier randomly organized cluster of cells.

3. Funding Restrictions and Political Shifts

In the United States, policy has historically been shaped by executive ideology rather than federal law. Ethical opposition led to a moratorium on federal funding for research involving the destruction of human embryos. While therapeutic cloning remains legal at the state level in some areas, researchers must often rely on private funding due to these federal restrictions. Some states have adopted “clone and kill” laws, which permit embryo destruction for research but strictly forbid uterine implantation.

4. International Declarations on “Human Dignity”

Ethical concerns have prevented the formation of a binding international treaty. Instead, the United Nations adopted a non-binding declaration in 2005 calling for a ban on all forms of human cloning—including therapeutic—that are “incompatible with human dignity and the protection of human life”. Similarly, the Council of Europe’s Oviedo Convention prohibits the creation of human embryos solely for research purposes.

5. Technical and Philosophical Re-categorization

To navigate these policy roadblocks, some scientific and philosophical proponents attempt to distinguish “cloned embryos” from “human embryos”. They argue that a cloned blastocyst in a laboratory is an “insentient cluster of cells” lacking “identity-preserving” potential, and therefore its destruction for life-saving research is morally justifiable compared to the status of a mature organism. Others seek “ethically flawless” alternatives, such as induced pluripotent stem cells (iPSCs), to bypass the need for embryos entirely

What biological limitations and developmental abnormalities currently hinder the safety of mammalian cloning?

The safety and viability of mammalian cloning, particularly through somatic cell nuclear transfer (SCNT), are currently hindered by extremely low efficiency rates, severe developmental abnormalities in offspring, and significant health risks to surrogate mothers.

Low Success Rates and High Mortality

SCNT remains a highly inefficient technique. For example, it took 277 attempts to produce a single live-born sheep (Dolly), and the first successfully cloned horse required 814 attempts. Current cloning success rates for familiar species like mice are roughly 9.4%, while for wild animals, the rate is usually less than 1%. Most cloned embryos fail to develop, and of those that do, a high percentage end in miscarriage or neonatal death. One bovine experiment noted that one-third of cloned calves died quite young.

Developmental Abnormalities in Offspring

Cloned mammals frequently exhibit a range of physical and physiological defects that are not common in natural reproduction:

• Large Offspring Syndrome (LOS): Offspring and their placentas are often significantly larger than normal, leading to excessive birth weight and difficulty breathing or feeding.

• Vital Organ Defects: Abnormalities are commonly observed in the liver, brain, heart, and kidneys. For instance, a cloned water buffalo and an extinct Pyrenean ibex died shortly after birth due to severe lung infections or defects.

• Physical Malformations: Clones may suffer from cleft palates, joint malformations (arthrogryposis), and umbilical hernias.

• Immune and Metabolic Issues: Cloned animals often have compromised immune systems, making them susceptible to infections, and may develop late-onset obesity.

Maternal Health Risks

The process poses severe risks to the surrogate mothers carrying cloned fetuses:

• Hydroallantois and Hydramnios: Cloned pregnancies frequently result in excessive fluid accumulation in the uterus, a condition that is extremely rare in normal pregnancies and can lead to maternal distress or death.

• Late-Gestational Loss: Unlike natural pregnancies where most losses occur early, cloned fetuses are often lost late in gestation, causing increased maternal morbidity.

Biological and Genetic Mechanisms of Failure

The root causes of these abnormalities are linked to errors in resetting the donor cell’s DNA:

• Nuclear Reprogramming Failures: Differentiated adult cells have “shut down” genes not needed for their specific functions; SCNT requires these genes to be “reset” to an embryonic state. This resetting is frequently incomplete or uncoordinated, leading to inappropriate gene expression.

• Genomic Imprinting Errors: Imprinting involves parent-specific chemical marks on DNA. In clones, these marks may not be maintained or copied correctly, leading to aberrant regulation of genes that control fetal growth, brain development, and placental function.

• Mitochondrial Heteroplasmy: Clones are not “perfect” copies because they inherit mitochondrial DNA (mtDNA) from the recipient egg rather than the nuclear donor. This can cause a nuclear-mitochondrial conflict, potentially triggering cell death or transplant rejection in therapeutic contexts.

• Telomere Shortening: Initial studies on Dolly suggested that clones might be born with a “genetic age” equivalent to the donor, evidenced by shorter telomeres (caps on chromosomes). While some research in mice and cattle suggests that telomeres can be rebuilt, the potential for premature aging remains a safety concern.

Primate and Human Specific Barriers

Cloning humans and other primates is technically more difficult due to the location of spindle proteins, which are essential for cell division. In primates, these proteins are situated so close to the chromosomes that removing the egg’s nucleus often removes the spindle proteins as well, effectively preventing the cell from dividing properly. Additionally, dyes and ultraviolet light used in the enucleation process can further damage primate cells.

Why are spindle proteins a major barrier in human cloning?

Spindle proteins represent a significant technical barrier in the cloning of humans and other primates due to their spatial location within the egg cell and their essential role in cellular reproduction,.

The specific reasons why these proteins hinder human cloning include:

• Inadvertent Removal During Enucleation: In primate eggs, two proteins essential for cell division are located in very close proximity to the chromosomes,. The foundational step of cloning—Somatic Cell Nuclear Transfer (SCNT)—requires the removal of the egg’s original nucleus to make room for a donor nucleus,. Because of their location, the act of removing the nucleus in primates unavoidably removes the spindle proteins as well,.

• Interference with Cell Division: Without these essential proteins, the reconstructed egg is unable to divide properly,. This failure prevents the egg from developing into a viable embryo,.

• Contrast with Other Species: This barrier is specific to primates; in other mammals frequently used in cloning research, such as mice, cats, and rabbits, these two spindle proteins are spread throughout the egg,. In those species, the nucleus can be removed without losing the proteins necessary for subsequent cell division,.

• Vulnerability to Technical Damage: Beyond the protein location itself, primate cells are highly sensitive to the laboratory environment,. The dyes and ultraviolet light often required to visualize and remove the egg’s nucleus can further damage the primate cell, preventing it from growing or reaching the blastocyst stage,.

Recent research suggests that failure to progress past the eight-cell stage in human SCNT may be linked to the nucleus’s inability to activate crucial embryonic genes, a process that might be hampered by the loss of factors physically linked to the original oocyte chromosomes during enucleation,. While modifications to culture liquids and electrical pulses have allowed for some breakthroughs in creating human embryonic stem cell lines, the abnormal chromosomal segregation and spindle assembly issues remain a primary reason why human reproductive cloning is not considered safe or feasible

Can mitochondrial DNA differences cause organ rejection in therapeutic cloning?

In therapeutic cloning involving somatic cell nuclear transfer (SCNT), the resulting cells are not exact genetic copies because they inherit mitochondrial DNA (mtDNA) from the recipient egg rather than the nuclear donor,. These divergent mitochondrial proteins can create “minor” transplantation antigens that the recipient’s immune system may identify as foreign,. Consequently, even when the major histocompatibility complex (MHC) is matched, these minor antigens—such as the maternally transmitted antigen Mta—can trigger an immune response and cause organ or tissue rejection,.

This immune-mediated response to “non-self” mtDNA may hamper the clinical benefits of patient-specific therapies by necessitating the use of immunosuppressive drugs,. Furthermore, a nuclear-mitochondrial conflict arising from genetic incompatibilities between the donor nucleus and the host egg’s mitochondria can lead to cell death or the failure of the embryo to develop past the eight-cell stage,. To circumvent these rejection issues, researchers suggest using an egg donated by the patient herself or the patient’s mother, which would ensure that the mitochondrial DNA is genetically identical to the recipient’s,. Another potential solution involves transferring mitochondria isolated from the patient’s own biopsies into the enucleated egg to avoid the presence of foreign mitochondrial genes.

References

Kfoury, C. (2007). Therapeutic cloning: promises and issues.
Lee, S. R., Lee, K. L., Song, S. H., Joo, M. D., Lee, S. H., Kang, J. S., Kang, S. M., Idrees, M., Kim, J. W., & Kong, I. K. (2024). Generation of Fel d 1 chain 2 genome-edited cats by CRISPR-Cas9 system. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-55464-0
Li, H., Wang, G., Hao, Z., Zhang, G., Qing, Y., Liu, S., Qing, L., Pan, W., Chen, L., Liu, G., Zhao, R., Jia, B., Zeng, L., Guo, J., Zhao, L., Zhao, H., Lv, C., Xu, K., Cheng, W., … Wei, H. J. (2016). Generation of biallelic knock-out sheep via gene-editing and somatic cell nuclear transfer. Scientific Reports, 6. https://doi.org/10.1038/srep33675
Loi, P., Czernik, M., Zacchini, F., Iuso, D., Scapolo, P. A., & Ptak, G. (2013). Sheep: The first large animal model in nuclear transfer research. Cellular Reprogramming, 15(5), 367–373. https://doi.org/10.1089/cell.2013.0032
Olsson, P. O., Jeong, Y. W., Jeong, Y., Kang, M., Park, G. B., Choi, E., Kim, S., Hossein, M. S., Son, Y. B., & Hwang, W. S. (2022). Insights from one thousand cloned dogs. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-15097-7
Wilmut, I., Schnieke, A., McWhir, J., Kind, A., & Campbell, K. (1997). Viable offspring derived from fetal and adult mammalian cells. Nature, 385.
Yang, L., Di, A., Song, L., Liu, X., Wu, D., Wang, S., Hao, Z., Bu, L., Bai, C., Su, G., Wei, Z., Zhang, L., Liu, Z., Gao, S., & Li, G. (2025). Generation of modified cows and sheep from spermatid-like haploid embryonic stem cells. Nature Biotechnology. https://doi.org/10.1038/s41587-025-02832-4
National Academy of Sciences (US), National Academy of Engineering (US), Institute of Medicine (US) and National Research Council (US) Committee on Science, Engineering, and Public Policy. Scientific and Medical Aspects of Human Reproductive Cloning. Washington (DC): National Academies Press (US); 2002. 2, Cloning: Definitions And Applications. Available from: https://www.ncbi.nlm.nih.gov/books/NBK223960/
https://www.geneious.com/guides/molecular-cloning-methods
https://learn.genetics.utah.edu/content/cloning/clonezone/
https://learn.genetics.utah.edu/content/cloning/whyclone/
https://www.newscientist.com/definition/cloning/
https://learn.genetics.utah.edu/content/cloning/cloningmyths/
https://learn.genetics.utah.edu/content/cloning/whatiscloning/
https://en.wikipedia.org/wiki/Propagation_of_grapevines
https://en.wikipedia.org/wiki/Somatic_cell_nuclear_transfer
https://en.wikipedia.org/wiki/Asexual_reproduction
https://en.wikipedia.org/wiki/Cloning
https://en.wikipedia.org/wiki/Molecular_cloning
https://en.wikipedia.org/wiki/Human_cloning
https://www.genome.gov/genetics-glossary/Cloning
https://www.neb.com/en/tools-and-resources/feature-articles/foundations-of-molecular-cloning-past-present-and-future?srsltid=AfmBOorFgxHMzNibk_IiCz_UmDG1gSm74RAPHxKD9wKS6inMiPvp9KMK
https://www.ebsco.com/research-starters/science/science-cloning
https://education.nationalgeographic.org/resource/cloning/
https://www.genome.gov/about-genomics/fact-sheets/Cloning-Fact-Sheet
https://www.nms.ac.uk/discover-catalogue/the-story-of-dolly-the-sheep
https://en.wikipedia.org/wiki/Dolly_(sheep)

Share

Related posts:

Molecular Scissors: An Introduction to Restriction Enzymes Artificial Chromosomes: YACs, BACs, MACs, HACs The Secret of the Blue and White Colonies: An Introduction to Blue-White Screening The Genetic Engineer’s Toolkit: A Beginner’s Guide to Cloning Vectors CRISPR Series: Unlocking the Code: A Beginner’s Guide to CRISPR-Cas9